Literature DB >> 8349607

A point mutation of alanine 163 to threonine is responsible for the defective secretion of high molecular weight kininogen by the liver of brown Norway Katholiek rats.

I Hayashi1, S Hoshiko, O Makabe, S Oh-ishi.   

Abstract

To clarify the mechanism of the secretion defect of high molecular weight kininogen (HK) and low molecular weight kininogen (LK) by the liver of Brown Norway (B/N) Katholiek rats causing plasma kininogen deficiency, we cloned cDNAs for HK from cDNA libraries of the livers of B/N Katholiek and B/N Kitasato rats. A point mutation of G to A at nucleotide 487 was found in the cDNA of B/N Katholiek rats by sequence analysis of the cDNAs (including the entire HK-coding region) obtained from both strains. Both B/N Katholiek and B/N Kitasato rat cDNA fragments were introduced into a eukaryotic vector, pRc/CMV, to construct their respective expression plasmid, which was used to transfect COS-1 cells. At 24 h of incubation, the culture medium of COS-1 cells transfected with the B/N Katholiek rat cDNA contained only 10% of the HK antigen that was found in COS-1 cells transfected with the B/N Kitasato rat cDNA. More HK antigen was retained in the former cells. Moreover, cells transfected with B/N Katholiek rat cDNA, in which the A at nucleotide 487 was artificially replaced by G, secreted a significant amount of HK into the medium. These results suggest that a point mutation of G to A at nucleotide 487, which causes a substitution of Ala163 to Thr in the heavy chain of HK and LK, is responsible for the defective secretion of HK and LK by the liver of B/N Katholiek rats.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8349607

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Reduction of sodium deoxycholic acid-induced scratching behaviour by bradykinin B2 receptor antagonists.

Authors:  I Hayashi; M Majima
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

2.  Blockade of bradykinin B(2) receptor suppresses acute pancreatitis induced by obstruction of the pancreaticobiliary duct in rats.

Authors:  Mitsuhiro Hirata; Izumi Hayashi; Kuniko Yoshimura; Ken-ichiro Ishii; Kazui Soma; Takashi Ohwada; Akira Kakita; Masataka Majima
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

3.  The myostimulating effect of tissue kallikrein on rat uterus.

Authors:  J Damas; V Bourdon; J C Pinto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-05       Impact factor: 3.000

Review 4.  Rat models of human diseases and related phenotypes: a systematic inventory of the causative genes.

Authors:  Claude Szpirer
Journal:  J Biomed Sci       Date:  2020-08-02       Impact factor: 8.410

5.  Bradykinin inhibits development of myocardial infarction through B2 receptor signalling by increment of regional blood flow around the ischaemic lesions in rats.

Authors:  Hiroshi Ito; Izumi Hayashi; Tohru Izumi; Masataka Majima
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

6.  A monoclonal antibody against kininogen reduces inflammation in the HLA-B27 transgenic rat.

Authors:  James C Keith; Irma M Sainz; Irma Isordia-Salas; Robin A Pixley; Yelena Leathurby; Leo M Albert; Robert W Colman
Journal:  Arthritis Res Ther       Date:  2005-04-04       Impact factor: 5.156

Review 7.  A Novel Category of Anti-Hypertensive Drugs for Treating Salt-Sensitive Hypertension on the Basis of a New Development Concept.

Authors:  Makoto Katori; Masataka Majima
Journal:  Pharmaceuticals (Basel)       Date:  2010-01-07

8.  The kallikrein-kinin pathway as a mechanism for auto-control of brown adipose tissue activity.

Authors:  Marion Peyrou; Rubén Cereijo; Tania Quesada-López; Laura Campderrós; Aleix Gavaldà-Navarro; Laura Liñares-Pose; Elena Kaschina; Thomas Unger; Miguel López; Marta Giralt; Francesc Villarroya
Journal:  Nat Commun       Date:  2020-05-01       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.